I agree with you I don't understand either. And blood products is a mature market. 20% profit growth I doubt will be sustainable. New products will be the drivers of growth eg gardisil
Will be very interesting what happens post feb 13 I agree. At this rate though I will be closing my trade.
I should have waited. Stupid me to much faith in my analysis not enough in trend. Trend is your friend.
new high soon, page-19
Add CSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$277.01 |
Change
-7.040(2.48%) |
Mkt cap ! $134.1B | |||
| Open | High | Low | Value | Volume |
| $280.67 | $281.07 | $275.01 | $254.8M | 915.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 13 | 1140 | $277.00 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $277.08 | 312 | 1 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| CSL (ASX) Chart |